Page 62 - ITPS-7-1

INNOSC Theranostics and
Pharmacological Sciences Management and maintenance of oral health

avascular bone necrosis. J Clin Oncol, 21: 4253–4254. 142: 1243–1251.
https://doi.org/10.1200/JCO.2003.99.132 https://doi.org/10.14219/jada.archive.2011.0108
16. Marx RE, 2003, Pamidronate (Aredia) and zoledronate 25. Beth-Tasdogan NH, Mayer B, Hussein H, et al.,
(Zometa) induced avascular necrosis of the jaws: A growing 2017, Interventions for managing medication-related
epidemic. J Oral Maxillofac Surg, 61: 1115–1117. osteonecrosis of the jaw. Cochrane Database Syst Rev, 10:
CD012432.
https://doi.org/10.1016/s0278-2391(03)00720-1
https://doi.org/10.1002/14651858.CD012432.pub2. Update
17. Kwoen MJ, Park JH, Kim KS, et al., 2023, Association
between periodontal disease, tooth extraction, and in: 2022, Cochrane Database Syst Rev, 7: CD012432.
medication-related osteonecrosis of the jaw in women 26. Di Fede O, Panzarella V, Mauceri R, et al., 2018, The dental
receiving bisphosphonates: A national cohort-based study. management of patients at risk of medication-related
J Periodontol, 94: 98–107. osteonec1rosis of the jaw: New paradigm of primary
prevention. Biomed Res Int, 2018: 2684924.
https://doi.org/10.1002/JPER.21-0611
https://doi.org/10.1155/2018/2684924
18. Wick A, Bankosegger P, Otto S, et al., 2022, Risk factors
associated with onset of medication-related osteonecrosis 27. Nicolatou-Galitis O, Schiødt M, Mendes RA, et al., 2019,
of the jaw in patients treated with denosumab. Clin Oral Medication-related osteonecrosis of the jaw: Definition and
Investig, 26: 2839–2852. best practice for prevention, diagnosis, and treatment. Oral
Surg Oral Med Oral Pathol Oral Radiol, 127: 117–135.
https://doi.org/10.1007/s00784-021-04261-4
https://doi.org/10.1016/j.oooo.2018.09.008
19. Troeltzsch M, Cagna D, Stähler P, et al., 2016, Clinical
features of peri-implant medication-related osteonecrosis 28. Al Abdullateef A, Alhareky MS, 2020, Awareness among
of the jaw: Is there an association to peri-implantitis? J patient at risk of developing medication related osteonecrosis
Craniomaxillofac Surg, 44: 1945–1951. of the jaw (MRONJ)-a primary prevention strategy. Saudi
Pharm J, 28: 771–778.
https://doi.org/10.1016/j.jcms.2016.09.018
https://doi.org/10.1016/j.jsps.2020.05.004
20. Landi L, Leali PT, Barbato L, et al., 2023, Anti-resorptive
therapy in the osteometabolic patient affected by periodontitis. 29. Steel BJ, 2019, Management of medication-related
A joint position paper of the Italian society of orthopaedics and osteonecrosis of the jaw (MRONJ) risk in patients due to
traumatology (SIOT) and the Italian society of periodontology commence anti-resorptive/anti-angiogenic drugs-how
and implantology (SIdP). J Orthop Traumatol, 24: 36. should pre-drug-treatment dental preventive care be
organised? Community Dent Health, 36: 244–254.
https://doi.org/10.1186/s10195-023-00713-7
https://doi.org/10.1922/CDH_4582Steel11
21. Wazzan T, Kashtwari D, Almaden WF, et al., 2018,
Radiographic bone loss and the risk of medication-related 30. Mosaico, G, Casu C, 2021, A primary prevention strategy:
osteonecrosis of the jaw (MRONJ) in multiple myeloma Oral hygiene and correct lifestyles among patients at risk
patients-a retrospective case control study. Spec Care Dentist, of developing drug-related osteonecrosis of the Jaw. Qeios,
38: 356–361. preprint.
https://doi.org/10.1111/scd.12318 https://doi.org/10.32388/bgmwyj
22. Mauceri R, Coniglio R, Abbinante A, et al., 2022, The 31. Ramaglia L, Guida A, Iorio-Siciliano V, et al., 2018, Stage-
preventive care of medication-related osteonecrosis of the specific therapeutic strategies of medication-related
jaw (MRONJ): A position paper by Italian experts for dental osteonecrosis of the jaws: A systematic review and meta-
hygienists. Support Care Cancer, 30: 6429–6440. analysis of the drug suspension protocol. Clin Oral Investig,
22: 597–615.
https://doi.org/10.1007/s00520-022-06940-8
https://doi.org/10.1007/s00784-017-2325-6
23. Elsayed R, El-Awady A, Cutler C, et al., 2021, Matrix-
bound zolzoledronate enhances the biofilm colonization of 32. Khan AA, Morrison A, Kendler DL, et al., 2017. Case-based
hydroxyapatite: Effects on osteonecrosis. Antibiotics (Basel), review of osteonecrosis of the jaw (ONJ) and application of
10: 1380. the international recommendations for management from
the international task force on ONJ. J Clin Densitom, 20: 8–24.
https://doi.org/10.3390/antibiotics10111380
https://doi.org/10.1016/j.jocd.2016.09.005
24. Hellstein JW, Adler RA, Edwards B, et al., 2011, Managing
the care of patients receiving antiresorptive therapy for 33. Kawahara M, Kuroshima S, Sawase T, 2021, Clinical
prevention and treatment of osteoporosis: Executive considerations for medication-related osteonecrosis of the
summary of recommendations from the American dental jaw: A comprehensive literature review. Int J Implant Dent,
association council on scientific affairs. J Am Dent Assoc, 7: 47.

Volume 7 Issue 1 (2024) 7 https://doi.org/10.36922/itps.1419